Report Detail
Global Antibody Therapeutics and Blood Antibody Therapeutics Market 2023 by Company, Regions, Type and Application, Forecast to 2029
- RnM4528559 |
- 13 April, 2023 |
- Global |
- 103 Pages |
- GIR (Global Info Research) |
- Other
Antibody, also called immunoglobulin, a protective protein produced by the immune system in response to the presence of a foreign substance, called an antigen. Antibodies recognize and latch onto antigens in order to remove them from the body. A wide range of substances are regarded by the body as antigens, including disease-causing organisms and toxic materials such as insect venom.
Treatment that uses antibodies to help the body fight cancer, infection, or other diseases. Antibodies are proteins made by the immune system that bind to specific markers on cells or tissues. IgG1 antibodies are a type of antibody made in the laboratory that can be used in diagnosis or treatment. In cancer treatment, IgG1 antibodies may kill cancer cells directly, they may block development of tumor blood vessels, or they may help the immune system kill cancer cells.
According to our (Global Info Research) latest study, the global Antibody Therapeutics and Blood Antibody Therapeutics market size was valued at USD 196950 million in 2022 and is forecast to a readjusted size of USD 371150 million by 2029 with a CAGR of 9.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The industry's leading producers are Roche, Abbvie and J & J, with revenues of 15.61%, 12.10% and 10.05% in 2019.
This report is a detailed and comprehensive analysis for global Antibody Therapeutics and Blood Antibody Therapeutics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Antibody Therapeutics and Blood Antibody Therapeutics market size and forecasts, in consumption value ($ Million), 2018-2029
Global Antibody Therapeutics and Blood Antibody Therapeutics market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Antibody Therapeutics and Blood Antibody Therapeutics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Antibody Therapeutics and Blood Antibody Therapeutics market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Antibody Therapeutics and Blood Antibody Therapeutics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Antibody Therapeutics and Blood Antibody Therapeutics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Abbvie, Johnson & Johnson, Bristol-Myers Squibb and Novartis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Antibody Therapeutics and Blood Antibody Therapeutics market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
IgG1
IgG4
Others
Market segment by Application
Autoimmune
Tumor
Others
Market segment by players, this report covers
Roche
Abbvie
Johnson & Johnson
Bristol-Myers Squibb
Novartis
Merck
Alexion Pharmaceuticals
Takeda
Amgen
Biogen
UCB
Eli Lilly and Company
AstraZeneca
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Antibody Therapeutics and Blood Antibody Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Antibody Therapeutics and Blood Antibody Therapeutics, with revenue, gross margin and global market share of Antibody Therapeutics and Blood Antibody Therapeutics from 2018 to 2023.
Chapter 3, the Antibody Therapeutics and Blood Antibody Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Antibody Therapeutics and Blood Antibody Therapeutics market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Antibody Therapeutics and Blood Antibody Therapeutics.
Chapter 13, to describe Antibody Therapeutics and Blood Antibody Therapeutics research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Antibody Therapeutics and Blood Antibody Therapeutics
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Antibody Therapeutics and Blood Antibody Therapeutics by Type
- 1.3.1 Overview: Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value Market Share by Type in 2022
- 1.3.3 IgG1
- 1.3.4 IgG4
- 1.3.5 Others
- 1.4 Global Antibody Therapeutics and Blood Antibody Therapeutics Market by Application
- 1.4.1 Overview: Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Autoimmune
- 1.4.3 Tumor
- 1.4.4 Others
- 1.5 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size & Forecast
- 1.6 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast by Region
- 1.6.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
- 1.6.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region, (2018-2029)
- 1.6.3 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Prospect (2018-2029)
- 1.6.4 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Prospect (2018-2029)
- 1.6.5 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Prospect (2018-2029)
- 1.6.6 South America Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Prospect (2018-2029)
- 1.6.7 Middle East and Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Prospect (2018-2029)
2 Company Profiles
- 2.1 Roche
- 2.1.1 Roche Details
- 2.1.2 Roche Major Business
- 2.1.3 Roche Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
- 2.1.4 Roche Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Roche Recent Developments and Future Plans
- 2.2 Abbvie
- 2.2.1 Abbvie Details
- 2.2.2 Abbvie Major Business
- 2.2.3 Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
- 2.2.4 Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Abbvie Recent Developments and Future Plans
- 2.3 Johnson & Johnson
- 2.3.1 Johnson & Johnson Details
- 2.3.2 Johnson & Johnson Major Business
- 2.3.3 Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
- 2.3.4 Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Johnson & Johnson Recent Developments and Future Plans
- 2.4 Bristol-Myers Squibb
- 2.4.1 Bristol-Myers Squibb Details
- 2.4.2 Bristol-Myers Squibb Major Business
- 2.4.3 Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
- 2.4.4 Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Bristol-Myers Squibb Recent Developments and Future Plans
- 2.5 Novartis
- 2.5.1 Novartis Details
- 2.5.2 Novartis Major Business
- 2.5.3 Novartis Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
- 2.5.4 Novartis Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Novartis Recent Developments and Future Plans
- 2.6 Merck
- 2.6.1 Merck Details
- 2.6.2 Merck Major Business
- 2.6.3 Merck Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
- 2.6.4 Merck Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Merck Recent Developments and Future Plans
- 2.7 Alexion Pharmaceuticals
- 2.7.1 Alexion Pharmaceuticals Details
- 2.7.2 Alexion Pharmaceuticals Major Business
- 2.7.3 Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
- 2.7.4 Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Alexion Pharmaceuticals Recent Developments and Future Plans
- 2.8 Takeda
- 2.8.1 Takeda Details
- 2.8.2 Takeda Major Business
- 2.8.3 Takeda Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
- 2.8.4 Takeda Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 Takeda Recent Developments and Future Plans
- 2.9 Amgen
- 2.9.1 Amgen Details
- 2.9.2 Amgen Major Business
- 2.9.3 Amgen Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
- 2.9.4 Amgen Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 Amgen Recent Developments and Future Plans
- 2.10 Biogen
- 2.10.1 Biogen Details
- 2.10.2 Biogen Major Business
- 2.10.3 Biogen Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
- 2.10.4 Biogen Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.10.5 Biogen Recent Developments and Future Plans
- 2.11 UCB
- 2.11.1 UCB Details
- 2.11.2 UCB Major Business
- 2.11.3 UCB Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
- 2.11.4 UCB Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.11.5 UCB Recent Developments and Future Plans
- 2.12 Eli Lilly and Company
- 2.12.1 Eli Lilly and Company Details
- 2.12.2 Eli Lilly and Company Major Business
- 2.12.3 Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
- 2.12.4 Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.12.5 Eli Lilly and Company Recent Developments and Future Plans
- 2.13 AstraZeneca
- 2.13.1 AstraZeneca Details
- 2.13.2 AstraZeneca Major Business
- 2.13.3 AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Product and Solutions
- 2.13.4 AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.13.5 AstraZeneca Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Share by Players (2018-2023)
- 3.2 Market Share Analysis (2022)
- 3.2.1 Market Share of Antibody Therapeutics and Blood Antibody Therapeutics by Company Revenue
- 3.2.2 Top 3 Antibody Therapeutics and Blood Antibody Therapeutics Players Market Share in 2022
- 3.2.3 Top 6 Antibody Therapeutics and Blood Antibody Therapeutics Players Market Share in 2022
- 3.3 Antibody Therapeutics and Blood Antibody Therapeutics Market: Overall Company Footprint Analysis
- 3.3.1 Antibody Therapeutics and Blood Antibody Therapeutics Market: Region Footprint
- 3.3.2 Antibody Therapeutics and Blood Antibody Therapeutics Market: Company Product Type Footprint
- 3.3.3 Antibody Therapeutics and Blood Antibody Therapeutics Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value and Market Share by Type (2018-2023)
- 4.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
- 5.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value Market Share by Application (2018-2023)
- 5.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Forecast by Application (2024-2029)
6 North America
- 6.1 North America Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Type (2018-2029)
- 6.2 North America Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Application (2018-2029)
- 6.3 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country
- 6.3.1 North America Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Country (2018-2029)
- 6.3.2 United States Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
- 6.3.3 Canada Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
- 6.3.4 Mexico Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
7 Europe
- 7.1 Europe Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Type (2018-2029)
- 7.2 Europe Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Application (2018-2029)
- 7.3 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country
- 7.3.1 Europe Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Country (2018-2029)
- 7.3.2 Germany Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
- 7.3.3 France Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
- 7.3.4 United Kingdom Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
- 7.3.5 Russia Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
- 7.3.6 Italy Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
8 Asia-Pacific
- 8.1 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Type (2018-2029)
- 8.2 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Application (2018-2029)
- 8.3 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Region
- 8.3.1 Asia-Pacific Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Region (2018-2029)
- 8.3.2 China Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
- 8.3.3 Japan Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
- 8.3.4 South Korea Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
- 8.3.5 India Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
- 8.3.6 Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
- 8.3.7 Australia Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
9 South America
- 9.1 South America Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Type (2018-2029)
- 9.2 South America Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Application (2018-2029)
- 9.3 South America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country
- 9.3.1 South America Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Country (2018-2029)
- 9.3.2 Brazil Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
- 9.3.3 Argentina Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
10 Middle East & Africa
- 10.1 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Type (2018-2029)
- 10.2 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Application (2018-2029)
- 10.3 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country
- 10.3.1 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Consumption Value by Country (2018-2029)
- 10.3.2 Turkey Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
- 10.3.3 Saudi Arabia Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
- 10.3.4 UAE Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast (2018-2029)
11 Market Dynamics
- 11.1 Antibody Therapeutics and Blood Antibody Therapeutics Market Drivers
- 11.2 Antibody Therapeutics and Blood Antibody Therapeutics Market Restraints
- 11.3 Antibody Therapeutics and Blood Antibody Therapeutics Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
- 11.5 Influence of COVID-19 and Russia-Ukraine War
- 11.5.1 Influence of COVID-19
- 11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
- 12.1 Antibody Therapeutics and Blood Antibody Therapeutics Industry Chain
- 12.2 Antibody Therapeutics and Blood Antibody Therapeutics Upstream Analysis
- 12.3 Antibody Therapeutics and Blood Antibody Therapeutics Midstream Analysis
- 12.4 Antibody Therapeutics and Blood Antibody Therapeutics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Antibody Therapeutics and Blood Antibody Therapeutics. Industry analysis & Market Report on Antibody Therapeutics and Blood Antibody Therapeutics is a syndicated market report, published as Global Antibody Therapeutics and Blood Antibody Therapeutics Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Antibody Therapeutics and Blood Antibody Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
